CA2143853C - Derives de substitution 2-aminoalkyl-5-aminoalkylamino d'isoquino-indazole-6-(2h)-ones, possedant une activite antitumorale - Google Patents
Derives de substitution 2-aminoalkyl-5-aminoalkylamino d'isoquino-indazole-6-(2h)-ones, possedant une activite antitumorale Download PDFInfo
- Publication number
- CA2143853C CA2143853C CA002143853A CA2143853A CA2143853C CA 2143853 C CA2143853 C CA 2143853C CA 002143853 A CA002143853 A CA 002143853A CA 2143853 A CA2143853 A CA 2143853A CA 2143853 C CA2143853 C CA 2143853C
- Authority
- CA
- Canada
- Prior art keywords
- amino
- ethyl
- indazole
- isoquino
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94160792A | 1992-09-08 | 1992-09-08 | |
US07/941,607 | 1992-09-08 | ||
US08/103,641 | 1993-08-11 | ||
US08/103,641 US5519029A (en) | 1992-09-08 | 1993-08-11 | 2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H)-ones |
PCT/US1993/008241 WO1994006795A1 (fr) | 1992-09-08 | 1993-09-08 | Isoquinoindazole-6-(2h)-ones a substitution 2-aminoalkyle-5-aminoalkylamino, a activite antitumorale |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2143853A1 CA2143853A1 (fr) | 1994-03-09 |
CA2143853C true CA2143853C (fr) | 2006-02-07 |
Family
ID=35890172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002143853A Expired - Lifetime CA2143853C (fr) | 1992-09-08 | 1993-09-08 | Derives de substitution 2-aminoalkyl-5-aminoalkylamino d'isoquino-indazole-6-(2h)-ones, possedant une activite antitumorale |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2143853C (fr) |
-
1993
- 1993-09-08 CA CA002143853A patent/CA2143853C/fr not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2143853A1 (fr) | 1994-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU218308B (en) | Indeno[2,1-c]quinolinone and indeno[2,1-b]-isoquinolinone derivatives and pharmaceutically acceptable salt thereof, preparation and use thereof | |
EP0503537B1 (fr) | 6,9-bis(amino substitué)benzo[9]isoquinoleines-5,10-diones | |
EP0376166A1 (fr) | Composé contenant un système condensé de quinoline et procédé pour sa préparation | |
EP0662076B1 (fr) | Isoquinoindazole-6-(2h)-ones a substitution 2-aminoalkyle-5-aminoalkylamino, a activite antitumorale | |
US5519029A (en) | 2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H)-ones | |
CA2143853C (fr) | Derives de substitution 2-aminoalkyl-5-aminoalkylamino d'isoquino-indazole-6-(2h)-ones, possedant une activite antitumorale | |
CA2183735C (fr) | Indazoles hetero-annelees | |
US5604246A (en) | 2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H)-ones | |
WO1992000281A1 (fr) | Agents anticancereux a base de 1,2-dihydro-3h-dibenzisoquinoline-1,3-diones | |
AU713107B2 (en) | New pyrido-thiopyranoindazoles with antitumor activity | |
WO1998049172A1 (fr) | Benzothiopyranopyridines regioisomeres a activite antitumorale | |
IE920704A1 (en) | Nitrogen oxides of aza- and diaza-anthracenedione¹derivatives as antitumor agents | |
US5935969A (en) | Pyrido-thiopyrandoinazoles with antitumor activity | |
EP1001936A1 (fr) | Bis-acridinecarboxamides ayant une activite antitumorale | |
WO1994005641A1 (fr) | SUBSTITUEES EN POSITION 4 PAR UN GROUPE AMINO BISUBSTITUE EN POSITION 6,9 BENZO[g]ISOQUINOLINE-5,10-DIONES | |
WO1998025910A1 (fr) | NOUVEAUX DERIVES DE 6-[(AMINOALKYL)AMINO]-7H-BENZO(e)-PERIMIDIN-7-ONE, LEUR PROCEDE DE PREPARATION ASSOCIE ET LEUR UTILISATION COMME MEDICAMENT | |
CA2006666A1 (fr) | Compose de systeme de guinoline condense et procede de preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |